<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Red blood cell survival: Normal values and measurement</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Red blood cell survival: Normal values and measurement</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Red blood cell survival: Normal values and measurement</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wilma Barcellini, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert A Brodsky, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer S Tirnauer, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 11, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>During its approximately four-month lifespan, the human red blood cell (RBC) travels approximately 300 miles, making approximately 170,000 circuits through the heart, enduring cycles of osmotic swelling and shrinkage while traveling through the kidneys and lungs, and an equal number of deformations while passing through capillary beds [<a href="#rid1">1,2</a>]. It has been speculated that accumulated damage to the RBC, especially to its membrane, renders the aging RBC unfit to circulate, leading to its destruction, via mechanisms that are poorly understood.</p><p>The normal time of RBC senescent (age-related) death in adults is approximately 110 to 120 days. Hemolysis can therefore be arbitrarily defined as a shortening in the survival of circulating RBCs to a value of less than 100 days.</p><p>This topic will review the mechanisms of normal RBC destruction and the methods used to measure RBC survival, which may be used in the evaluation of patients with suspected hemolysis [<a href="#rid3">3</a>]. Approaches to the patient with hemolytic anemia and with anemia in general are presented separately. (See  <a class="medical medical_review" href="/d/html/7076.html" rel="external">"Diagnosis of hemolytic anemia in adults"</a> and  <a class="medical medical_review" href="/d/html/7133.html" rel="external">"Diagnostic approach to anemia in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MECHANISMS OF RBC DESTRUCTION</span><span class="headingEndMark"> — </span>RBCs are normally destroyed by two different mechanisms, one related to increasing RBC age (senescence) and the other to a random process that destroys intact RBCs, or portions of an intact RBC (eg, vesicles) independent of their age (random hemolysis). These two processes may not be fully independent of one another [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Senescence</span><span class="headingEndMark"> — </span>Virtually all RBCs die of processes associated with "wear and tear" associated with prolonged circulation within the intravascular space, unless another cause of RBC destruction intervenes first. These processes include, but are not limited to [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Shearing forces across high pressure areas in the circulation, such as the aortic valve.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple deformations subsequent to passage through capillaries and splenic cords.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple cycles of osmotic swelling and shrinkage when passing through the lung and kidneys [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oxidative challenges to the RBC from transported oxygen molecules and circulating oxidant molecules and immune-mediated mechanisms. As an example, age- and in vitro storage-dependent oxidation of band 3, the major membrane transmembrane protein, increases the affinity of anti-band 3 antibodies [<a href="#rid7">7,8</a>]. Such antibodies, when membrane bound, lead to partial complement activation on the red cell surface, which may be associated with decreased red cell deformability [<a href="#rid9">9</a>]. These complement components in turn are recognized by complement receptors on macrophages and removed from the circulation [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A slow decline in RBC enzyme activity with advancing age, since the initial endowment of a RBC cannot be replaced during its lifespan.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decreased RBC deformability and increased sphericity due to progressive loss of surface area (membrane) with time.</p><p></p><p>Senescent death takes place mainly in the spleen, within the cords of Billroth. These unique vascular channels end blindly, unlike others in the body. The only way for an RBC, which has a diameter of 7 to 8 microns, to escape from these cords and return to the general circulation is to deform sufficiently to pass through 2 to 4 micron slits in the walls of the cords (<a class="graphic graphic_picture graphicRef53105" href="/d/graphic/53105.html" rel="external">picture 1</a>). Cells that negotiate this process survive; those that cannot find themselves in a hostile environment, surrounded by cells of the monocyte-macrophage system. It is at this stage that senescent signals on the RBC membrane are detected by phagocytic cells [<a href="#rid11">11</a>]. Aging cells that fail this quality control step lose part or all of their membrane, with approximately two to three million RBCs being destroyed per second through these processes.</p><p>Senescent death or survival of RBCs can be approximated mathematically by a Gaussian distribution (the "bell shaped" curve), with a mean time to senescent death (mean potential RBC lifespan) of approximately 110 to 120 days in adults [<a href="#rid5">5,12-14</a>]. Senescence signals most likely arise from alterations in membrane proteins on the surface of aging RBC [<a href="#rid15">15</a>]. Candidate processes include exposure of cryptic alpha-galactosyl residues or phosphatidylserine on the RBC surface, alterations in the anion transporter (band 3) protein, altered expression or recognition of CD45 or CD47 on the red cell surface, increased membrane immunoglobulin, and accumulated membrane damage and stiffness from the effects of reactive oxygen species [<a href="#rid16">16-24</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Random RBC death</span><span class="headingEndMark"> — </span>The rate of random or age-independent RBC destruction is normally quite low, in the range of less than 0.05 to 0.5 percent per day; this value can be appreciably increased in hemolytic states, especially when destruction in an enlarged spleen is part of the hemolytic process [<a href="#rid12">12</a>]. It has been estimated that, in healthy individuals, up to 20 percent of the RBC's content of hemoglobin is lost during its lifespan secondary to loss of membrane-bound hemoglobin by the process of vesiculation [<a href="#rid4">4,25</a>].</p><p class="headingAnchor" id="H3338102313"><span class="h1">ESTIMATION OF RED CELL SURVIVAL FROM THE RETICULOCYTE COUNT</span><span class="headingEndMark"> — </span>A less accurate but clinically useful estimate of RBC survival can be obtained from easily available information such as the reticulocyte percentage (or preferably, the absolute reticulocyte count) and hemoglobin or hematocrit. This is based upon the fact that, to maintain a constant RBC mass, the bone marrow must produce as many new RBCs (reticulocytes) per day as are being destroyed. (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children", section on 'Reticulocyte count'</a> and  <a class="medical medical_review" href="/d/html/7076.html" rel="external">"Diagnosis of hemolytic anemia in adults", section on 'High reticulocyte count'</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">HISTORICAL METHODS FOR DETERMINING RBC LIFESPAN</span><span class="headingEndMark"> — </span>Three general methods are available for accurate determination of the RBC lifespan: </p><p class="bulletIndent1"><span class="glyph">●</span>Random labeling of RBCs</p><p class="bulletIndent1"><span class="glyph">●</span>Cohort labeling of RBCs</p><p class="bulletIndent1"><span class="glyph">●</span>Kinetic studies of iron, bilirubin (and other bile pigments), or carbon monoxide metabolism</p><p></p><p>An historical review of RBC survival methodologies is available [<a href="#rid3">3</a>], beginning with the Ashby differential RBC agglutination studies initially published in 1919 [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H3563332"><span class="h2">Utility of RBC survival studies</span><span class="headingEndMark"> — </span>With few exceptions, all of the above methods for determination of RBC survival entailed the use of radioactive or nonradioactive isotopes, were time-consuming, expensive, and required the patient to be in a steady state throughout the study. However, such studies were instrumental in our gaining an accurate understanding of RBC production and physiologic destruction, as well as mechanisms of increased turnover in various disorders of hematopoiesis such as aplastic anemia, pernicious anemia, thalassemia, and the various hemolytic anemias.</p><p>RBC survival studies are rarely employed in the 21<sup>st</sup> century for studies in individual patients, as routine laboratory studies for detecting intravascular and extravascular hemolysis are routinely available (eg, LDH, indirect bilirubin, haptoglobin, urine for cell-free hemoglobin and hemosiderin). A candidate for such studies might be the rare patient with anemia in whom the underlying mechanism is unclear. (See  <a class="medical medical_review" href="/d/html/7076.html" rel="external">"Diagnosis of hemolytic anemia in adults"</a>.)</p><p>However, research applications of RBC survival methods have produced important evidence for the evaluation of RBC storage media, the effects of agents employed to improve RBC survival in the hemolytic anemias, and understanding the relationship between RBC survival and hemoglobin A1c levels in people with diabetes [<a href="#rid3">3,27-30</a>]. As an example, a study that measured the relative survival of RBCs stored at refrigerator temperature for different durations (one to five weeks versus six weeks) by transfusing six volunteers with <sup>51</sup>Cr labeled red cells and determining the recovery of bilirubin and non-transferrin-bound iron markers found that RBC survival decreased and hemolysis increased progressively with longer storage times [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/7072.html" rel="external">"Structure and function of normal hemoglobins", section on 'Glycated hemoglobins (hemoglobin A1C)'</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Random label RBC survival methods</span></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="120386" href="/d/drug information/120386.html" rel="external">Biotin</a><strong>/avidin method</strong> – This method has been used in clinical research studies when it becomes important to determine the lifespan of the entire population (or selected subpopulations) of RBCs. It is not used clinically. An aliquot of RBCs was labeled in vitro with biotin, washed to remove unreacted reagent, reinfused into the subject, and activity periodically monitored by reacting a sample of blood with fluorescein-labeled avidin or streptavidin, followed by flow cytometric quantitation of fluorescein-labeled RBC as a percentage of the total [<a href="#rid3">3,32-36</a>]. This method had the added advantage that serial studies could be performed in the same subject by utilizing differing concentrations of biotin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Radioactive labeling</strong> – In this method, which is of historic interest, a sample of circulating RBC, containing cells of all ages, was labeled in vitro with a radioactive isotope (such as <sup>51</sup>Cr or <sup>32</sup>P-labeled di-isopropylfluorophosphate) and reinfused into the patient. Blood samples were removed periodically, and survival was measured from the resulting plot of RBC radioactivity versus time after injection. While these techniques could also be used to determine blood volume, two major parameters of RBC survival could be obtained: the RBC half-time and the time of RBC senescence. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential agglutination</strong> – The Ashby differential agglutination method, which is also mainly of historic interest, was based upon administration of type O blood into a subject with type A or B blood and serially measuring the number of non-agglutinated RBC as a function of time following injection [<a href="#rid26">26</a>]. This method cannot be used to determine the survival of autologous RBC.</p><p></p><p class="headingAnchor" id="H8"><span class="h3">RBC half-time</span><span class="headingEndMark"> — </span>The RBC half-time is the time at which activity in the patient's circulating RBCs falls to one-half of the initial (or 24-hour) value. For a "perfect" label, such as <sup>32</sup>P-labeled di-isopropylfluorophosphate (DFP) or <a class="drug drug_general" data-topicid="120386" href="/d/drug information/120386.html" rel="external">biotin</a>, this occurs at 55 to 60 days (ie, the normal RBC lifespan divided by two). However, the most commonly used radioactive isotope in the past for this purpose (<sup>51</sup>Cr) was not a perfect label, and eluted from the RBC at a rate of approximately 1 percent per day [<a href="#rid37">37</a>]. Thus, when employing <sup>51</sup>Cr, the observed half-time was shorter than the theoretical value, in the range of 28 to 37 days for healthy adults [<a href="#rid32">32,37</a>], with values as low as 5 to 10 days in individuals with sickle cell anemia [<a href="#rid38">38,39</a>].</p><p>While corrections can be made to adjust for label elution, the <sup>51</sup>Cr half-time was used directly as a semiquantitative measure of RBC lifespan. Its advantage over the cohort method described below (see <a class="local">'Cohort labeling technique'</a> below) was that an estimate of RBC survival could be obtained in less than two weeks.</p><p class="headingAnchor" id="H9"><span class="h2">Time of RBC senescence</span><span class="headingEndMark"> — </span>When a random label technique was employed, the time of RBC senescence could be measured by sampling the patient's blood until activity was no longer detected on circulating RBCs. The time when the last labeled RBC has left the circulation was called the "extinction time"; this represents the time of death, by senescence, of labeled reticulocytes present in the original sample. This value is equal to the mean potential lifespan of the person's RBCs, averaging 120 days (range: 100 to 132 days) in adults without hemolytic disorders [<a href="#rid32">32,35,37</a>].</p><p>Similar reasoning applied to the determination of the lifespan of fetal red cells transfused into the maternal circulation via an unplanned, large volume fetomaternal hemorrhage [<a href="#rid40">40</a>]. In one report, fetal red cells, as measured by blood type-based flow cytometry, remained within the maternal circulation for 15 to 17 weeks (105 to 119 days) following delivery, indicating a lifespan similar to that of adult red cells [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Sites of RBC destruction</span><span class="headingEndMark"> — </span>Chromium-51 studies were also used to detect the sites of RBC destruction, by placing radiation-sensitive probes over the liver and spleen. This technique was used to document the presence of dominant splenic (rather than hepatic) sequestration in patients with hemolytic anemia [<a href="#rid42">42,43</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Cohort labeling technique</span><span class="headingEndMark"> — </span>The cohort labeling technique, also of historical interest, involved the administration of a radioactive precursor of hemoglobin, such as <sup>14</sup>C-labeled glycine or a non-radioactive precursor such as <sup>15</sup>N-labled glycine. These metabolic precursors were rapidly incorporated into hemoglobin heme, producing a group (or cohort) of labeled RBC of defined age [<a href="#rid13">13,14</a>]. Their survival could be determined by repeated sampling of blood for labeled heme or stool for labeled bile pigments (eg, stercobilin). The rate of random hemolysis and the mean potential RBC lifespan could be obtained via analysis of the resulting curves of activity versus time after isotope injection [<a href="#rid14">14</a>]. Such studies are no longer available.</p><p class="headingAnchor" id="H12"><span class="h2">Quantitative erythrokinetic studies</span><span class="headingEndMark"> — </span>Erythropoiesis could be quantitated following the intravenous injection of labeled transferrin-bound iron (<sup>59</sup>Fe or <sup>55</sup>Fe) [<a href="#rid44">44</a>]. Using appropriate kinetic models, rates of erythropoiesis and estimates of RBC survival could be obtained [<a href="#rid44">44-46</a>]. These studies could provide information concerning the presence or absence of ineffective erythropoiesis, hepatic and splenic erythropoiesis, and splenic sequestration [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H19582868"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Modes of RBC destruction</strong> – Red blood cells (RBCs) are destroyed by two different mechanisms. These two processes may not be fully independent of one another. (See <a class="local">'Mechanisms of RBC destruction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Senescence</strong> – Destruction related to age-related alterations in the RBC.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The average time for senescence death of the RBC (also called the mean potential lifespan) in adults is 110 to 120 days. (See <a class="local">'Senescence'</a> above and <a class="local">'Time of RBC senescence'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>When random RBC labeling techniques are used, the RBC half-time (when half of the labeled cells have left the circulation) is 55 to 60 days for a "perfect" (non-eluting) label such as <a class="drug drug_general" data-topicid="120386" href="/d/drug information/120386.html" rel="external">biotin</a> and 28 to 37 days for an eluting label such as <sup>51</sup>Cr. (See <a class="local">'RBC half-time'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Random hemolysis</strong> – Random hemolysis is due to processes that destroy intact RBCs or portions of an intact RBC independent of cell age. Most clinical conditions associated with shortened RBC lifespan are of this type, including autoimmune hemolytic anemia and RBC destruction in sickle cell disease. (See <a class="local">'Random RBC death'</a> above and  <a class="medical medical_review" href="/d/html/7076.html" rel="external">"Diagnosis of hemolytic anemia in adults", section on 'Conceptual framework'</a>.)</p><p></p><p class="bulletIndent2">The rate of random hemolysis has been estimated to be &lt;0.5 percent per day in adults. (See <a class="local">'Random RBC death'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Methods for estimating RBC survival</strong> – RBC survival studies were frequently used during the second half of the 20<sup>th</sup> century and were instrumental in fostering understanding of RBC production and destruction in health and disease. They have limited clinical utility in the modern era and are mainly of historical interest. (See <a class="local">'Utility of RBC survival studies'</a> above.)</p><p></p><p class="bulletIndent1">Examples include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Random or cohort RBC labeling techniques. (See <a class="local">'Random label RBC survival methods'</a> above and <a class="local">'Cohort labeling technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Determination of iron or bilirubin turnover. (See <a class="local">'Quantitative erythrokinetic studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reticulocyte counts</strong> – A less accurate but clinically useful estimate of RBC survival can be obtained from the patient's reticulocyte percentage (or preferably, absolute reticulocyte count) and hemoglobin or hematocrit, along with an estimate of the reticulocyte lifespan within the circulation. (See <a class="local">'Estimation of red cell survival from the reticulocyte count'</a> above.)</p><p></p><p class="headingAnchor" id="H372126330"><span class="h1">ACKNOWLEDGMENTS</span></p><p>UpToDate gratefully acknowledges Stanley L Schrier, MD (deceased), who contributed as Section Editor on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Hematology.</p><p>The UpToDate editorial staff also acknowledges the extensive contributions of William C Mentzer, MD, to earlier versions of this and many other topic reviews.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">ALLISON AC. Turnovers of erythrocytes and plasma proteins in mammals. Nature 1960; 188:37.</a></li><li><a class="nounderline abstract_t">Lux SE. Spectrin-actin membrane skeleton of normal and abnormal red blood cells. Semin Hematol 1979; 16:21.</a></li><li><a class="nounderline abstract_t">Franco RS. The measurement and importance of red cell survival. Am J Hematol 2009; 84:109.</a></li><li><a class="nounderline abstract_t">Willekens FL, Werre JM, Groenen-Döpp YA, et al. Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 2008; 141:549.</a></li><li><a class="nounderline abstract_t">Landaw SA. Factors that accelerate or retard red blood cell senescence. Blood Cells 1988; 14:47.</a></li><li><a class="nounderline abstract_t">Li CK, Li EK. Mechanical fatigue as a possible determinant of in vivo longevity of red blood cells. IEEE Trans Biomed Eng 1983; 30:226.</a></li><li><a class="nounderline abstract_t">Arese P, Turrini F, Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005; 16:133.</a></li><li><a class="nounderline abstract_t">Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion 2007; 47:1212.</a></li><li><a class="nounderline abstract_t">Karnchanaphanurach P, Mirchev R, Ghiran I, et al. C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex. J Clin Invest 2009; 119:788.</a></li><li><a class="nounderline abstract_t">Zaninoni A, Fermo E, Vercellati C, et al. Congenital Hemolytic Anemias: Is There a Role for the Immune System? Front Immunol 2020; 11:1309.</a></li><li><a class="nounderline abstract_t">Korolnek T, Hamza I. Macrophages and iron trafficking at the birth and death of red cells. Blood 2015; 125:2893.</a></li><li><a class="nounderline abstract_t">EADIE GS, BROWN IW Jr. The potential life span and ultimate survival of fresh red blood cells in normal healthy recipients as studied by simultaneous Cr51 tagging and differential hemolysis. J Clin Invest 1955; 34:629.</a></li><li><a class="nounderline abstract_t">CLINE MJ, BERLIN NI. Red blood cell life span using DFP as a cohort label. Blood 1962; 19:715.</a></li><li><a class="nounderline abstract_t">SHEMIN D, RITTENBERG D. The life span of the human red blood cell. J Biol Chem 1946; 166:627.</a></li><li><a class="nounderline abstract_t">Tartakover-Matalon S, Shoham-Kessary H, Foltyn V, Gershon H. Receptors involved in the phagocytosis of senescent and diamide-oxidized human RBCs. Transfusion 2000; 40:1494.</a></li><li><a class="nounderline abstract_t">Galili U, Flechner I, Knyszynski A, et al. The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol 1986; 62:317.</a></li><li><a class="nounderline abstract_t">Kay MM, Wyant T, Goodman J. Autoantibodies to band 3 during aging and disease and aging interventions. Ann N Y Acad Sci 1994; 719:419.</a></li><li><a class="nounderline abstract_t">Kuypers FA, Yuan J, Lewis RA, et al. Membrane phospholipid asymmetry in human thalassemia. Blood 1998; 91:3044.</a></li><li><a class="nounderline abstract_t">Gifford SC, Derganc J, Shevkoplyas SS, et al. A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence. Br J Haematol 2006; 135:395.</a></li><li><a class="nounderline abstract_t">Marinkovic D, Zhang X, Yalcin S, et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest 2007; 117:2133.</a></li><li><a class="nounderline abstract_t">Khandelwal S, van Rooijen N, Saxena RK. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation. Transfusion 2007; 47:1725.</a></li><li><a class="nounderline abstract_t">Burger P, Hilarius-Stokman P, de Korte D, et al. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 2012; 119:5512.</a></li><li><a class="nounderline abstract_t">Franco RS, Puchulu-Campanella ME, Barber LA, et al. Changes in the properties of normal human red blood cells during in vivo aging. Am J Hematol 2013; 88:44.</a></li><li><a class="nounderline abstract_t">Sosale NG, Rouhiparkouhi T, Bradshaw AM, et al. Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II. Blood 2015; 125:542.</a></li><li><a class="nounderline abstract_t">Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Döpp YA, et al. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003; 101:747.</a></li><li><a class="nounderline abstract_t">Ashby W. THE DETERMINATION OF THE LENGTH OF LIFE OF TRANSFUSED BLOOD CORPUSCLES IN MAN. J Exp Med 1919; 29:267.</a></li><li><a class="nounderline abstract_t">Khera PK, Smith EP, Lindsell CJ, et al. Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation. Am J Hematol 2015; 90:50.</a></li><li><a class="nounderline abstract_t">Zeiler T, Müller JT, Hasse C, et al. Flow cytometric determination of RBC survival in autoimmune hemolytic anemia. Transfusion 2001; 41:493.</a></li><li><a class="nounderline abstract_t">Strauss RG, Mock DM, Widness JA, et al. Posttransfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion 2004; 44:871.</a></li><li><a class="nounderline abstract_t">Risitano AM, Notaro R, Marando L, et al. Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood 2009; 113:4094.</a></li><li><a class="nounderline abstract_t">Rapido F, Brittenham GM, Bandyopadhyay S, et al. Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest 2017; 127:375.</a></li><li><a class="nounderline abstract_t">Mock DM, Lankford GL, Widness JA, et al. Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion 1999; 39:156.</a></li><li><a class="nounderline abstract_t">Cowley H, Wojda U, Cipolone KM, et al. Biotinylation modifies red cell antigens. Transfusion 1999; 39:163.</a></li><li><a class="nounderline abstract_t">Valeri CR, MacGregor H, Giorgio A, et al. Comparison of radioisotope methods and a nonradioisotope method to measure the RBC volume and RBC survival in the baboon. Transfusion 2003; 43:1366.</a></li><li><a class="nounderline abstract_t">Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008; 112:4284.</a></li><li><a class="nounderline abstract_t">Mock DM, Matthews NI, Zhu S, et al. Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. Transfusion 2011; 51:1047.</a></li><li><a class="nounderline abstract_t">MOLLISON PL. Further observations on the normal survival curve of 51 Cr-labelled red cells. Clin Sci 1961; 21:21.</a></li><li><a class="nounderline abstract_t">Guis MS, Lande WM, Mohandas N, et al. Prolongation of sickle cell survival by dimethyl adipimidate is compromised by immune sensitization. Blood 1984; 64:161.</a></li><li><a class="nounderline abstract_t">McCurdy PR, Sherman AS. Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR. Am J Med 1978; 64:253.</a></li><li><a class="nounderline abstract_t">Sebring ES, Polesky HF. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990; 30:344.</a></li><li><a class="nounderline abstract_t">Dziegiel MH, Koldkjaer O, Berkowicz A. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells. Transfusion 2005; 45:539.</a></li><li><a class="nounderline abstract_t">Najean Y, Cacchione R, Dresch C, Rain JD. Methods of evaluating the sequestration site of red cells labelled with 51Cr: a review of 96 cases. Br J Haematol 1975; 29:495.</a></li><li><a class="nounderline abstract_t">Recommended method for radioisotope red-cell survival studies. International Committee for Standardization in Haematology. Br J Haematol 1980; 45:659.</a></li><li><a class="nounderline abstract_t">HUFF RL, HENNESSY TG, AUSTIN RE, et al. Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders. J Clin Invest 1950; 29:1041.</a></li><li><a class="nounderline abstract_t">Ricketts C, Jacobs A, Cavill I. Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe. Br J Haematol 1975; 31:65.</a></li><li><a class="nounderline abstract_t">Pollycove M. Iron metabolism and kinetics. Semin Hematol 1966; 3:235.</a></li></ol></div><div id="topicVersionRevision">Topic 7082 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13682590" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Turnovers of erythrocytes and plasma proteins in mammals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/370983" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Spectrin-actin membrane skeleton of normal and abnormal red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19025796" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The measurement and importance of red cell survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18419623" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Erythrocyte vesiculation: a self-protective mechanism?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3052634" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Factors that accelerate or retard red blood cell senescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6862501" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Mechanical fatigue as a possible determinant of in vivo longevity of red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16301814" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17581156" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19258706" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32655575" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Congenital Hemolytic Anemias: Is There a Role for the Immune System?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25778532" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Macrophages and iron trafficking at the birth and death of red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14367517" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The potential life span and ultimate survival of fresh red blood cells in normal healthy recipients as studied by simultaneous Cr51 tagging and differential hemolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13879962" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Red blood cell life span using DFP as a cohort label.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20276177" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The life span of the human red blood cell.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11134570" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Receptors involved in the phagocytosis of senescent and diamide-oxidized human RBCs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3947551" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7516632" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Autoantibodies to band 3 during aging and disease and aging interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9531618" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Membrane phospholipid asymmetry in human thalassemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16989660" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17671650" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Foxo3 is required for the regulation of oxidative stress in erythropoiesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17725740" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22427202" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : CD47 functions as a molecular switch for erythrocyte phagocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23115087" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Changes in the properties of normal human red blood cells during in vivo aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25411427" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12393566" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19868318" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : THE DETERMINATION OF THE LENGTH OF LIFE OF TRANSFUSED BLOOD CORPUSCLES IN MAN.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25293624" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11316900" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Flow cytometric determination of RBC survival in autoimmune hemolytic anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15157254" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Posttransfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19179465" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27941245" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prolonged red cell storage before transfusion increases extravascular hemolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10037125" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10037126" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Biotinylation modifies red cell antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14507266" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Comparison of radioisotope methods and a nonradioisotope method to measure the RBC volume and RBC survival in the baboon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18694998" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21062290" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13771880" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Further observations on the normal survival curve of 51 Cr-labelled red cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6733268" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prolongation of sickle cell survival by dimethyl adipimidate is compromised by immune sensitization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/629275" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2190367" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15819674" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1191561" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Methods of evaluating the sequestration site of red cells labelled with 51Cr: a review of 96 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7426443" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Recommended method for radioisotope red-cell survival studies. International Committee for Standardization in Haematology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15436873" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1212437" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5341720" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Iron metabolism and kinetics.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
